Table 1.
Characteristics of the Patients at Baseline and Postintervention
| Variable | Baseline | Postintervention |
|---|---|---|
| Patient visits, No. | ||
| UTI | 1562 | 1512 |
| SSTI | 1378 | 1292 |
| PNA | 1184 | 1250 |
| VAP | 55 | 73 |
| Age, median (IQR), y | ||
| UTI | 57 (45 to 68) | 57 (43 to 68) |
| SSTI | 50 (39 to 58) | 49.5 (38 to 58) |
| PNA | 57 (46 to 68) | 57 (47 to 67) |
| VAP | 54 (37 to 64) | 56 (40 to 64) |
| Female gender, No. (%) | ||
| UTI | 913 (58) | 880 (58) |
| SSTI | 367 (27) | 359 (28) |
| PNA | 432 (36) | 463 (37) |
| VAP | 15 (27) | 20 (27) |
| Medicaid/Medicare, %/% | ||
| UTI | 72/20 | 73/21 |
| SSTI | 82/8 | 79/12 |
| PNA | 69/21 | 70/21 |
| VAP | 64/22 | 71/18 |
| DRG relative weight, median (IQR) | ||
| UTI | 1.16 (0.98 to 1.79) | 1.17 (0.93 to 1.77) |
| SSTI | 1.11 (0.84 to 1.75) | 1.27 (0.84 to 1.77) |
| PNA | 1.79 (1.43 to 2.63) | 1.77 (1.32 to 2.45) |
| VAP | 5.13 (2.30 to 10.94) | 5.11 (3.25 to 10.92) |
| Expected mortality, median (IQR), % | ||
| UTI | 0.75 (0.18 to 2.2) | 0.75 (0.18 to 2.4) |
| SSTI | 0.18 (0.05 to 0.88) | 0.19 (0.05 to 1.05) |
| PNA | 1.4 (0.55 to 5.7) | 1.5 (0.50 to 5.6) |
| VAP | 10.3 (1.3 to 24.3) | 10.4 (2.1 to 30.5) |
| Procalcitonin ordered, No. (%) | ||
| UTI | N/A | 276 (18) |
| SSTI | N/A | 157 (12) |
| PNA | N/A | 587 (47) |
| VAP | N/A | 47 (64) |
Abbreviations: DRG, diagnostic-related group; IQR, interquartile range; PNA, pneumonia; SSTI, skin and skin structure infection; UTI, urinary tract infection; VAP, ventilator-associated pneumonia.